Learn more about our services and treatment options at Transcend Headache Clinic
Ostergaard L, Stankevicius E, Andersen MR, Eskildsen-Helmond Y, Ledet T, Mulvany MJ, Simonsen U (2007) Diminished NO release in chronic hypoxic human endothelial cells
GLP-1 medicines mimic this naturally occurring hormone, reducing hunger and food intake, which can lead to weight loss
Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Eli J
Voor een kuur van 2 tot 3 maanden: 2 capsules per dag bij het ontbijt met een groot glas water